Cathie Wood's position in Repare Therapeutics is currently worth $1.56 Million. That's 0.01% of their equity portfolio (145th largest holding). The investor owns 2.75% of the outstanding Repare Therapeutics stock. The first Repare Therapeutics trade was made in Q4 2020. Since then Cathie Wood bought shares six more times and sold shares on eleven occasions. The investor's estimated purchase price is $32.5 Million, resulting in a loss of 95%.